Tuberous Sclerosis or Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the growth of numerous benign tumors (hamartomas) in many parts of the body including the brain, heart, lungs, eyes, kidneys, skin and other organs, leading to seizures, intellectual disability, autism or developmental delay. 1, 3 TSC is an autosomal dominant disorder with an incidence of approximately 1 in 5000 to 10,000 live births .3-5 It presents with variable clinical manifestations together with angiofibromas distributed in a characteristic "butterfly" pattern on the face and forehead. TSC occurs in all races and ethnic groups, and in both genders.
Case Summery
An 11 month old completely immunized boy of a nonconsanguineous parents hailing from Shariatpur was admitted at Dhaka Shishu Hospital on 23 January 2017 with the complaints of-abnormal jerky movement of both limbs and head for 2 months and Excessive cry for the same duration.
The movement was initially irregular with short duration (few seconds to minutes) and used to resolve spontaneously. But gradually it increases in duration and intensity. For the last fifteen days it became more frequent and nearly uncontrolled.
The Baby was delivered by LUCS at term at hospital without any complication. He was exclusively breastfed upto 6 months then complimentary feeding was started with khichuri and milk suzi. Developmentally he was age appropriate. There was no history of unconsciousness, hematuria or respiratory distress or any family history of such type of illness.
With these complaints he was treated with some homeopathic medication but as the condition did not improve then he was admitted in to Dhaka Shishu Hospital.
On Examination the baby was irritable without any active convulsion. His vital signs were normal and anthropometrically he was age appropriate.
Skin survey revealed BCG mark was present. There were multiple hypopigmented areas over trunk and extremities, the largest one located on the back measuring about 2x1cm in diameter.
Regarding systemic examination we found that his Nervous, Respiratory, Cardiac and Renal system reveals normal. Provisionally we thought of Neurocuteneous syndrome, Tuberous Sclerosis with Infantile spasm.
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On admission we treat the baby with Normal diet and Syrup
Phenobarbitone. CBC, Serum Electrolyte, Serum Calcium, Random Blood Sugar, Chest X-ray findings were with in normal limit.
But his USG brain revealed-Prominent of frontal horn, Ventricular index was 30% (Normal), Thickened Sulci. EEG showed abnormality with background activity with epileptiform discharges. and advised to correlate clinically with West syndrome. MRI Showed that Presence of cortical tuber with Candle dripping appearance.
Therefore, finally we diagnose the patient as a Neurocuteneous
Syndrome-Tuberous Sclerosis. After final diagnosis patient was discharged on request with syrup Phenobarbiton as with this drug symptom were subsided. We asked the parents to come with the baby for follow-up after one month.
Discussion
The baby was presented with abnormal jerky movement of both limbs and head for 2 months since his 7 months of age and excessive cry for the same duration. He had typical multiple hypopigmented area of skin (Ash leaf spots) specially over the trunk, which was clinically consistent with Tuberous Sclerosis.
MRI report was also consistent with Tuberous sclerosis.
Therefore, with the history of recurrent seizure, hypomelanotic macules (Ash leaf spots) and supportive evidences from imaging suggests the diagnosis of Tuberous Sclerosis. In addition he had clinical evidence of epilepsy, which was confirmed by EEG.
Tuberous sclerosis (TS) is also known as Bourneville disease, named after the French physician who described a series of patients with this illness in 1880. 6 TS is thought to be result from sporadic mutation in the majority (Two-thirds ) of patients, since most patients have no family history of the disease. 2 But their offspring may inherit it from them. It is caused by a mutation in either the TSC1 gene or the TSC2 gene. TSC1 and TSC2 which code for the protein hamartin and tuberin respectively. These proteins act as tumor growth suppressor agents that regulate cell proliferation and differentiation.
The triad of symptoms of TS, as described by Vogt, 7 consists of seizure, adenoma sebaceum (facial angiofibroma) and mental retardation. Not all patients have this classic triad, however, and half of all patients are of normal intellect and a quarter do not have seizures. 8 Although facial angiofibromas are commonly described as the hamartomatous lesions of TS, hamartomas may involve virtually any organ.
The diagnostic criteria of TSC have been divided into major and minor features. Conference. 11 Everolimus also showed evidence of effectiveness at treating epilepsy in some people with TSC. 12 In 2017, the The frequency of signs in children with TSC, grouped by age 9 
